Embodiments of topical formulations for administering cerdulatinib or a pharmaceutically acceptable salt, hydrate or solvate thereof are disclosed. Embodiments of methods for preparing the topical formulations are also disclosed. The disclosed formulations are suitable for the treatment of dermatologic conditions such as atopic dermatitis.本發明揭示用於給予賽度替尼(cerdulatinib)或其醫藥上可接受之鹽、水合物或溶劑合物之外用調配物之具體實例。亦揭示用於製備該外用調配物之方法之具體實例。所揭示之調配物適用於治療皮膚症狀，例如異位性皮膚炎。
